Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nicole Massoll

Concepts (246)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
9
2022
116
1.250
 Why?
Thyroid Nodule
5
2022
31
1.110
 Why?
Carcinoma, Papillary
4
2017
51
0.640
 Why?
Biopsy, Fine-Needle
7
2024
104
0.590
 Why?
Uterus
2
2008
88
0.510
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
62
0.510
 Why?
Papillomavirus Infections
2
2008
172
0.450
 Why?
Breast Neoplasms
7
2018
1205
0.380
 Why?
Vulvar Neoplasms
3
2008
60
0.340
 Why?
Carcinoma, Squamous Cell
4
2008
330
0.340
 Why?
Cysts
2
2006
51
0.310
 Why?
MicroRNAs
3
2022
388
0.300
 Why?
Uterine Cervical Neoplasms
2
2008
299
0.280
 Why?
Uterine Cervical Dysplasia
1
2008
51
0.280
 Why?
Precancerous Conditions
1
2008
85
0.280
 Why?
Carcinoma, Lobular
1
2007
32
0.260
 Why?
Cytological Techniques
1
2006
13
0.260
 Why?
Carcinoma, Ductal, Breast
1
2007
89
0.250
 Why?
Adenomyoma
1
2005
2
0.240
 Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.240
 Why?
Carcinoma in Situ
2
2008
72
0.240
 Why?
Gynecologic Surgical Procedures
1
2005
29
0.240
 Why?
Biopsy, Needle
1
2006
182
0.240
 Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
17
0.230
 Why?
Uterine Neoplasms
1
2005
59
0.230
 Why?
Lymph Nodes
3
2017
252
0.230
 Why?
Competency-Based Education
1
2024
28
0.220
 Why?
Carcinoma, Medullary
1
2004
12
0.220
 Why?
Humans
34
2024
52513
0.210
 Why?
Fellowships and Scholarships
1
2024
125
0.200
 Why?
Adenocarcinoma, Follicular
1
2002
4
0.200
 Why?
Mastectomy
2
2018
143
0.200
 Why?
Thyrotropin
1
2002
49
0.200
 Why?
Clinical Competence
1
2024
400
0.180
 Why?
Pathology
3
2024
37
0.180
 Why?
Focal Adhesion Kinase 1
2
2012
14
0.170
 Why?
Female
21
2020
28219
0.170
 Why?
Diagnostic Tests, Routine
1
2020
31
0.170
 Why?
Diagnosis, Differential
4
2008
1045
0.170
 Why?
Carcinoma, Neuroendocrine
1
2020
25
0.170
 Why?
Mutation
6
2022
1342
0.170
 Why?
DNA, Neoplasm
2
2018
146
0.160
 Why?
Lung Neoplasms
2
2015
633
0.150
 Why?
Proto-Oncogene Proteins B-raf
2
2017
80
0.150
 Why?
Protein Kinase Inhibitors
2
2012
228
0.150
 Why?
Immunohistochemistry
6
2015
981
0.140
 Why?
Thyroid Gland
3
2020
78
0.140
 Why?
Pancreatic Neoplasms
2
2010
210
0.130
 Why?
Gene Silencing
2
2008
120
0.130
 Why?
Middle Aged
11
2020
13081
0.130
 Why?
Neoplasm Invasiveness
5
2015
278
0.130
 Why?
DNA, Viral
2
2008
138
0.130
 Why?
Sensitivity and Specificity
4
2020
882
0.120
 Why?
PTEN Phosphohydrolase
1
2016
55
0.120
 Why?
Pulmonary Medicine
1
2015
14
0.120
 Why?
Fibroblasts
2
2016
359
0.120
 Why?
Cytodiagnosis
1
2015
42
0.120
 Why?
Cell Proliferation
4
2016
1027
0.110
 Why?
Adult
10
2020
14148
0.110
 Why?
Aged, 80 and over
6
2020
3414
0.110
 Why?
Endosonography
1
2015
96
0.110
 Why?
Lymphatic Metastasis
3
2017
211
0.110
 Why?
Granuloma
2
2007
47
0.110
 Why?
Receptor, erbB-2
2
2018
80
0.100
 Why?
Laryngeal Diseases
1
2013
12
0.100
 Why?
Herpes Simplex
1
2013
23
0.100
 Why?
Laryngectomy
1
2013
27
0.100
 Why?
Purine Nucleosides
1
2012
3
0.100
 Why?
Receptor, IGF Type 1
1
2012
22
0.100
 Why?
Immunoenzyme Techniques
2
2008
136
0.090
 Why?
Cell Movement
2
2009
275
0.090
 Why?
Predictive Value of Tests
2
2020
949
0.090
 Why?
Receptors, Somatomedin
1
2010
8
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
5
0.080
 Why?
Tissue Fixation
2
2020
36
0.080
 Why?
Melanoma
1
2012
279
0.080
 Why?
Aniline Compounds
1
2009
46
0.080
 Why?
Promoter Regions, Genetic
2
2008
474
0.080
 Why?
Retrospective Studies
5
2022
6661
0.080
 Why?
Aged
6
2020
10181
0.070
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.070
 Why?
Neuroblastoma
1
2008
51
0.070
 Why?
Transglutaminases
1
2008
14
0.070
 Why?
Proto-Oncogene Proteins c-met
1
2007
19
0.070
 Why?
Mastitis
1
2007
3
0.070
 Why?
Biopsy
2
2007
603
0.070
 Why?
GTP-Binding Proteins
1
2008
82
0.070
 Why?
Genetic Markers
1
2008
109
0.070
 Why?
Genes, erbB-2
1
2007
8
0.070
 Why?
Prednisone
1
2007
102
0.070
 Why?
Gene Expression Regulation, Enzymologic
1
2008
181
0.070
 Why?
Group Practice
1
2006
3
0.070
 Why?
Intracellular Signaling Peptides and Proteins
1
2007
136
0.070
 Why?
Cystatins
1
2006
1
0.070
 Why?
Cadherins
1
2007
63
0.060
 Why?
Frozen Sections
1
2006
13
0.060
 Why?
Genomic Instability
1
2007
89
0.060
 Why?
Specialization
1
2006
49
0.060
 Why?
Colonic Neoplasms
1
2008
163
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
582
0.060
 Why?
Polymerase Chain Reaction
2
2005
460
0.060
 Why?
Tumor Suppressor Protein p53
1
2008
224
0.060
 Why?
Medicine
1
2006
53
0.060
 Why?
Mice
6
2017
5943
0.060
 Why?
Nuclear Proteins
1
2007
246
0.060
 Why?
RNA, Small Interfering
3
2012
218
0.060
 Why?
Antigens, CD
1
2007
215
0.060
 Why?
Gene Expression
1
2008
623
0.060
 Why?
Mullerian Ducts
1
2005
4
0.060
 Why?
Carrier Proteins
1
2007
319
0.060
 Why?
Fallopian Tubes
1
2005
23
0.060
 Why?
Estrogen Replacement Therapy
1
2005
28
0.060
 Why?
Medical Oncology
1
2006
103
0.060
 Why?
Signal Transduction
1
2012
1707
0.060
 Why?
Chromosome Aberrations
1
2007
297
0.060
 Why?
Data Collection
1
2006
289
0.060
 Why?
ABO Blood-Group System
1
2005
15
0.060
 Why?
Vulva
1
2005
18
0.060
 Why?
Ovariectomy
1
2005
113
0.060
 Why?
Glucocorticoids
1
2007
238
0.060
 Why?
Hysterectomy
1
2005
91
0.060
 Why?
Mice, Nude
3
2010
235
0.060
 Why?
Decision Making
1
2007
282
0.060
 Why?
Regression Analysis
1
2006
402
0.060
 Why?
Carcinoma, Transitional Cell
1
2005
54
0.060
 Why?
Epithelial Cells
1
2006
214
0.060
 Why?
Papillomaviridae
1
2005
105
0.060
 Why?
Cell Survival
3
2012
602
0.060
 Why?
Male
7
2020
26816
0.060
 Why?
Epigenesis, Genetic
1
2008
403
0.050
 Why?
Cell Line, Tumor
4
2009
1435
0.050
 Why?
Ultrasonography
1
2006
424
0.050
 Why?
Cohort Studies
2
2020
1551
0.050
 Why?
Base Sequence
3
2010
634
0.050
 Why?
Prospective Studies
2
2022
2451
0.050
 Why?
Gene Expression Regulation
1
2007
1004
0.050
 Why?
Education, Medical, Graduate
1
2024
217
0.050
 Why?
Thyroidectomy
1
2002
61
0.050
 Why?
Gene Expression Profiling
1
2007
1108
0.050
 Why?
Adolescent
3
2015
6725
0.050
 Why?
Yersinia pseudotuberculosis
1
2001
3
0.040
 Why?
Yersinia Infections
1
2001
6
0.040
 Why?
Yersinia enterocolitica
1
2001
6
0.040
 Why?
Animals
6
2017
13464
0.040
 Why?
Recombinant Proteins
1
2002
495
0.040
 Why?
Combined Modality Therapy
1
2002
636
0.040
 Why?
Formaldehyde
1
2020
51
0.040
 Why?
Oncogenes
1
2020
60
0.040
 Why?
Appendicitis
1
2001
66
0.040
 Why?
Disease Progression
3
2008
872
0.040
 Why?
Cell Differentiation
1
2002
673
0.040
 Why?
Neoplasm Staging
2
2015
767
0.040
 Why?
Transplantation, Heterologous
2
2010
78
0.040
 Why?
Toxicology
1
1999
28
0.040
 Why?
Antineoplastic Agents
1
2008
1219
0.040
 Why?
Blotting, Western
2
2012
593
0.040
 Why?
DNA Methylation
3
2008
583
0.040
 Why?
DNA Primers
2
2010
206
0.040
 Why?
Young Adult
2
2020
4326
0.040
 Why?
Paraffin Embedding
1
2018
52
0.040
 Why?
Specimen Handling
1
2018
56
0.040
 Why?
Receptors, Progesterone
1
2018
66
0.040
 Why?
Receptors, Estrogen
1
2018
132
0.030
 Why?
Methylene Blue
1
2017
7
0.030
 Why?
Lymphatic System
1
2017
12
0.030
 Why?
Animals, Genetically Modified
1
2017
52
0.030
 Why?
Coloring Agents
1
2017
68
0.030
 Why?
Mice, Inbred Strains
1
2017
164
0.030
 Why?
Prognosis
2
2015
2115
0.030
 Why?
Follow-Up Studies
2
2015
2290
0.030
 Why?
Treatment Outcome
1
2006
5480
0.030
 Why?
Apoptosis
2
2012
1120
0.030
 Why?
Cost Savings
1
2015
58
0.030
 Why?
Neoplasm Grading
1
2015
126
0.030
 Why?
Mice, Knockout
2
2008
910
0.030
 Why?
RNA, Messenger
2
2008
1139
0.030
 Why?
Collagen
1
2016
213
0.030
 Why?
Cost-Benefit Analysis
1
2015
269
0.030
 Why?
Tumor Microenvironment
1
2016
254
0.030
 Why?
Immunoprecipitation
1
2012
57
0.020
 Why?
In Situ Nick-End Labeling
1
2012
54
0.020
 Why?
Flow Cytometry
1
2012
400
0.020
 Why?
Cell Line
1
2012
1030
0.020
 Why?
Staurosporine
1
2009
10
0.020
 Why?
Deoxycytidine
1
2009
28
0.020
 Why?
Drug Synergism
1
2009
148
0.020
 Why?
Cell Adhesion
1
2009
164
0.020
 Why?
RNA Interference
1
2009
186
0.020
 Why?
Xenograft Model Antitumor Assays
1
2009
222
0.020
 Why?
Polymorphism, Single-Stranded Conformational
1
2008
19
0.020
 Why?
Luciferases
1
2008
50
0.020
 Why?
Chromatin Immunoprecipitation
1
2008
49
0.020
 Why?
Adenoviridae
1
2008
47
0.020
 Why?
Florida
1
2008
67
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
68
0.020
 Why?
Fluorouracil
1
2008
58
0.020
 Why?
Loss of Heterozygosity
1
2008
78
0.020
 Why?
Histone Deacetylase 2
1
2007
4
0.020
 Why?
Phosphorylation
1
2009
529
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2008
95
0.020
 Why?
Transcriptional Activation
1
2008
128
0.020
 Why?
Co-Repressor Proteins
1
2007
18
0.020
 Why?
Estrogens
1
2009
223
0.020
 Why?
Sequence Deletion
1
2007
72
0.020
 Why?
Drug Screening Assays, Antitumor
1
2008
136
0.020
 Why?
Transfection
1
2008
368
0.020
 Why?
Molecular Chaperones
1
2007
77
0.020
 Why?
Histone Deacetylases
1
2007
51
0.020
 Why?
Enzyme Inhibitors
1
2009
371
0.020
 Why?
Ultrasonography, Mammary
1
2007
61
0.020
 Why?
Tumor Cells, Cultured
1
2007
448
0.020
 Why?
Kaplan-Meier Estimate
1
2008
485
0.020
 Why?
Molecular Sequence Data
1
2008
770
0.020
 Why?
Transcription, Genetic
1
2008
379
0.020
 Why?
Chromatin
1
2007
141
0.020
 Why?
Cystatin M
1
2006
19
0.020
 Why?
5' Untranslated Regions
1
2006
30
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Repressor Proteins
1
2007
153
0.020
 Why?
Carcinoma
1
2007
137
0.020
 Why?
Down-Regulation
1
2007
344
0.020
 Why?
Wound Healing
1
2007
219
0.020
 Why?
Cesarean Section
1
2007
184
0.020
 Why?
Protein Binding
1
2007
671
0.020
 Why?
Survival Rate
1
2008
952
0.010
 Why?
Gene Expression Regulation, Neoplastic
1
2009
856
0.010
 Why?
Cells, Cultured
1
2008
1587
0.010
 Why?
Chi-Square Distribution
1
2005
295
0.010
 Why?
Neoplasm Recurrence, Local
1
2008
642
0.010
 Why?
Pregnancy Complications
1
2007
399
0.010
 Why?
Child
2
2008
7218
0.010
 Why?
Tomography, X-Ray Computed
1
2007
1161
0.010
 Why?
Appendix
1
2001
23
0.010
 Why?
Infant, Newborn
1
2008
2884
0.010
 Why?
DNA, Bacterial
1
2001
176
0.010
 Why?
Magnetic Resonance Imaging
1
2007
1535
0.010
 Why?
Pregnancy
1
2007
2672
0.010
 Why?
Environmental Medicine
1
1999
1
0.010
 Why?
Occupational Medicine
1
1999
3
0.010
 Why?
History, Ancient
1
1999
10
0.010
 Why?
Forensic Medicine
1
1999
7
0.010
 Why?
History, 19th Century
1
1999
23
0.010
 Why?
Infant
1
2008
3713
0.010
 Why?
Child, Preschool
1
2008
4056
0.010
 Why?
Risk Factors
1
2008
3951
0.010
 Why?
History, 20th Century
1
1999
96
0.010
 Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (246) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department